Want to join the conversation?
$AMGN and Brussels-based biopharma company UCB announced the submission of a Biologics License Application (BLA) to the US FDA for romosozumab, an investigational antibody for treating osteoporosis in postmenopausal women at increased risk of fracture. The BLA is based on data from Phase 3 placebo-controlled FRAME study in about 7,200 patients.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.